Results

Total Results: 589 records

Showing results for "chlamydia".

  1. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
    September 24, 2015 - Chlamydia screening 8. Dental visits 9. Preventive dental visits 10. BMI 11. … 96.67% Children’s and Adolescents’ Access to Primary Care 93.33% Dental Treatment Services 93.33% Chlamydia
  2. www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
    September 24, 2015 - Chlamydia screening 8. Dental visits 9. Preventive dental visits 10. BMI 11. … 96.67% Children’s and Adolescents’ Access to Primary Care 93.33% Dental Treatment Services 93.33% Chlamydia
  3. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
    September 24, 2015 - Chlamydia screening 8. Dental visits 9. Preventive dental visits 10. BMI 11. … 96.67% Children’s and Adolescents’ Access to Primary Care 93.33% Dental Treatment Services 93.33% Chlamydia
  4. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
    September 24, 2015 - Chlamydia screening 8. Dental visits 9. Preventive dental visits 10. BMI 11. … 96.67% Children’s and Adolescents’ Access to Primary Care 93.33% Dental Treatment Services 93.33% Chlamydia
  5. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
    September 24, 2015 - Chlamydia screening 8. Dental visits 9. Preventive dental visits 10. BMI 11. … 96.67% Children’s and Adolescents’ Access to Primary Care 93.33% Dental Treatment Services 93.33% Chlamydia
  6. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
    September 24, 2015 - Chlamydia screening 8. Dental visits 9. Preventive dental visits 10. BMI 11. … 96.67% Children’s and Adolescents’ Access to Primary Care 93.33% Dental Treatment Services 93.33% Chlamydia
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/ndk2qMLMrpq_DLV5ddEQFd
    August 22, 2023 - • A bacterial sexually transmitted infection (syphilis, gonorrhea, or chlamydia for men who have sex … • A bacterial sexually transmitted infection (STI) (syphilis, gon- orrhea, or chlamydia for men who … syphi- lis in pregnant24 and nonpregnant25 persons, screening for genital herpes,26 screening for chlamydia … [n = 10 775]; RR, 1.08 [95% CI, 0.98-1.18]), gonorrhea (5 trials; RR, 1.07 [95% CI, 0.82- 1.39]), chlamydia … Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement.
  8. www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/genital-herpes-serologic-screening
    August 16, 2022 - Behavioral counseling interventions to prevent STIs 14 Screening for chlamydia and gonorrhea 15 Screening … Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement.
  9. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/sexually-transmitted-infections-behavioral-counseling
    August 02, 2018 - papillomavirus (HPV), herpes simplex virus (HSV) type 1 and 2, hepatitis B and C viruses, Zika virus, chlamydia
  10. www.ahrq.gov/research/findings/studies/index.html?page=46
    January 01, 2024 - Continuing Medical Education, Education: Curriculum Teixeira da Silva D , Petsis D , Santos T Chlamydia … This study describes retesting following Chlamydia trachomatis/Neisseria gonorrhea (CT/NG) diagnosis … Chlamydia trachomatis/neisseria gonorrhea retesting among adolescents and young adults in a primary care
  11. www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/research/engaging-challenging-full.pdf
    May 01, 2024 - /chlamydia- and-gonorrhea-screening . … https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening … Chlamydia/gonorrhea Recommendation for general age group (grade B):57 ▪ Screening in all sexually active … "healthy diet" OR "lung cancer" OR osteoporosis OR fracture* OR "abdominal aortic aneurysm" OR "chlamydia … "healthy diet" OR "lung cancer" OR osteoporosis OR fracture* OR "abdominal aortic aneurysm" OR "chlamydia
  12. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    June 11, 2019 - 42 There were no significant differences between PrEP vs placebo or no PrEP in risk of gonorrhea, chlamydia … statistically significant interaction between PrEP regimen and any adverse event except for gonorrhea and chlamydia … an open-label RCT and nonrandomized studies found PrEP associated with an increased risk of rectal chlamydia … (4 studies; odds ratio, 1.59 [95% CI, 1.19-2.13]) but found no association between PrEP and risk of chlamydia … women 3 27 , 42 , 43 1.20 (0.76-1.92) 69      MSM 2 17 , 31 1.05 (0.85-1.30) 0 Chlamydia
  13. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
    June 11, 2019 - 42 There were no significant differences between PrEP vs placebo or no PrEP in risk of gonorrhea, chlamydia … statistically significant interaction between PrEP regimen and any adverse event except for gonorrhea and chlamydia … an open-label RCT and nonrandomized studies found PrEP associated with an increased risk of rectal chlamydia … (4 studies; odds ratio, 1.59 [95% CI, 1.19-2.13]) but found no association between PrEP and risk of chlamydia … women 3 27 , 42 , 43 1.20 (0.76-1.92) 69      MSM 2 17 , 31 1.05 (0.85-1.30) 0 Chlamydia
  14. www.ahrq.gov/research/findings/studies/index.html?page=277
    January 01, 2024 - Wynn A , Ramogola-Masire D , Gaolebale P Prevalence and treatment outcomes of routine Chlamydia … Prevalence and treatment outcomes of routine Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas
  15. untitled (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/AnLwG-T96XaL_TCZ6TPcWe
    March 07, 2017 - diagnostic accuracy for any gynecologic cancer or condition except cervical cancer, gonorrhea, and chlamydia … effective screening approaches are recommended (eg, nucleic acid amplification test for gonorrhea and chlamydia … for cervical can- cer (such as Papanicolaou and human papillomavirus cotesting) and for gonorrhea and chlamydia … Cervical cancer, gonorrhea, and chlamydia were not included because other effec- tive screening tests … Screening for chlamydia and gonorrhea: U.S.
  16. www.ahrq.gov/prevention/guidelines/guide/section2b.html
    June 01, 2014 - Other Relevant USPSTF Recommendations The USPSTF has made recommendations on screening for chlamydia … screening of pregnant women for other infections, including asymptomatic bacteriuria, bacterial vaginosis, chlamydia
  17. www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/assess-resident-RTI-slides.pptx
    June 01, 2021 - WBC Chest films show infiltrates, possible effusions *Bacterial causes include Mycoplasma pneumoniae, Chlamydia
  18. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    August 22, 2023 - trials; n = 9296; RR, 1.07 [95% CI, 0.82-1.39]; I 2 = 49%) (eFigure 14 in the  JAMA  Supplement), chlamydia … Condomless anal sex with ≥2 partners in the previous 12 wk or syphilis, rectal gonorrhea, or rectal chlamydia … 0.91-1.06)    Syphilis: 15% (413/2694) vs 15% (392/2693); RR, 1.05 (95% CI, 0.93-1.20)    Urethral chlamydia … receiving PrEP Moderate for no difference See applicability for KQ1, oral PrEP vs placebo Chlamydia … receiving PrEP Moderate for no difference See applicability for KQ1, oral PrEP vs placebo Chlamydia
  19. www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/prevention/lifestyle/healthy-women.pdf
    May 01, 2014 - Get screened for chlamydia and gonorrhea infections if you are 24 years or younger and sexually active
  20. ce.effectivehealthcare.ahrq.gov/sites/default/files/publications2/files/measure-retirement-2013.pdf
    January 01, 2013 - Chlamydia Screening in Women 0033 National Committee for Quality Assurance 10. … Chlamydia Screening – sexually active females ages 16-20 – Number of female Medicaid/CHIP enrollees … Measure Name Chlamydia Screening in Women 4.b. … Chlamydia Screening in Women 6.75 (15) 6.50 (22) 5 No change 18. … Chlamydia Screening in Women SNAC members expressed mixed sentiments about this measure.